FY2024 EPS Estimates for Amedisys Reduced by William Blair

Amedisys, Inc. (NASDAQ:AMED) – Equities researchers at William Blair decreased their FY2024 earnings per share estimates for shares of Amedisys in a research note issued to investors on Thursday, November 7th. William Blair analyst M. Larew now forecasts that the health services provider will post earnings per share of $4.40 for the year, down from their prior estimate of $4.72. The consensus estimate for Amedisys’ current full-year earnings is $4.65 per share. William Blair also issued estimates for Amedisys’ Q4 2024 earnings at $1.05 EPS and Q3 2025 earnings at $1.10 EPS.

Other equities research analysts also recently issued research reports about the company. Cantor Fitzgerald reissued a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft downgraded Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price objective on the stock. in a report on Monday, July 29th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $100.67.

Amedisys Trading Down 0.1 %

NASDAQ AMED opened at $96.71 on Monday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. Amedisys has a twelve month low of $89.55 and a twelve month high of $98.95. The company has a market cap of $3.17 billion, a price-to-earnings ratio of 38.38, a price-to-earnings-growth ratio of 1.92 and a beta of 0.78. The business’s fifty day moving average is $96.70 and its 200 day moving average is $95.89.

Amedisys (NASDAQ:AMED) last released its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.34%. The firm had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same period last year, the business earned $0.98 EPS. The company’s revenue was up 5.7% compared to the same quarter last year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC lifted its holdings in Amedisys by 41.6% during the 2nd quarter. SG Americas Securities LLC now owns 38,315 shares of the health services provider’s stock worth $3,517,000 after buying an additional 11,264 shares during the period. BNP Paribas Financial Markets lifted its holdings in Amedisys by 111.7% during the 1st quarter. BNP Paribas Financial Markets now owns 12,050 shares of the health services provider’s stock worth $1,111,000 after buying an additional 6,358 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock worth $47,202,000 after buying an additional 19,660 shares during the period. California State Teachers Retirement System lifted its stake in shares of Amedisys by 65.8% in the 1st quarter. California State Teachers Retirement System now owns 54,592 shares of the health services provider’s stock valued at $5,031,000 after purchasing an additional 21,671 shares during the period. Finally, Cetera Advisors LLC acquired a new position in shares of Amedisys in the 1st quarter valued at about $1,556,000. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.